Day: August 9, 2021

Company reports continued improvement in APT segment, updates forecast for expected future after-tax net RC cash flows of $30 million to $40 million GREENWOOD VILLAGE, Colo., Aug. 09, 2021 (GLOBE NEWSWIRE) — Advanced Emissions Solutions, Inc. (NASDAQ: ADES) (the “Company” or “ADES”) today filed its Quarterly Report on Form 10-Q and reported financial results for the quarter ended June 30, 2021, including information about its equity investments in Tinuum Group, LLC (“Tinuum Group”) and Tinuum Services, LLC (“Tinuum Services”) (collectively “Tinuum”), of which ADES owns 42.5% and 50%, respectively. Tinuum & Refined Coal (“RC”) HighlightsTinuum’s second quarter distributions to ADES totaled $20.6 million compared to $15.4 million in the prior year’s quarter. Royalty...

HOLMDEL, N.J., Aug. 09, 2021 (GLOBE NEWSWIRE) — Vonage Holdings Corp. (NYSE: VG), a global leader in cloud communications helping businesses accelerate their digital transformation, today announced that management is scheduled to present at the following investor conferences: Oppenheimer 24th Annual Technology, Internet & Communications Conference (Virtual)Tuesday, August 10 at 2:55 PM ET KeyBanc 22nd Annual Technology Leadership Forum (Virtual)Wednesday, August 11 at 1:20 PM ET A live webcast and replay of each event will be available on the Vonage Investor Relations site. About Vonage Vonage (Nasdaq:VG), a global cloud communications leader, helps businesses accelerate their digital transformation. Vonage’s Communications Platform is fully programmable and allows for the integration of Video, Voice, Chat, Messaging...

NEW HAVEN, Conn., Aug. 09, 2021 (GLOBE NEWSWIRE) — BIOASIS TECHNOLOGIES INC. (TSXV:BTI; OTCQB:BIOAF), (the “Company” or “Bioasis”), a pre-clinical, research-stage biopharmaceutical company developing its proprietary xB3™ platform technology to enhance the delivery of biologics across the blood-brain barrier (“BBB”) for the treatment of central nervous system (“CNS”) disorders in areas of high unmet medical need, including brain cancers and neurodegenerative diseases, today announced that the Japanese Patent Office (“JPO”) issued Japanese Patent No. 2019-189551 Notice of Allowance for the Company’s xB3-IDS fusion proteins. The patent relates to fusion proteins between Bioasis’ xB3™ and Iduronate-2-sulfatase (IDS), and compositions and methods related to the use thereof. The issued claims of this patent cover the compositions for...

TORONTO, Aug. 09, 2021 (GLOBE NEWSWIRE) — Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein, Executive Chairman, will speak at the Canaccord Genuity 41st Annual Growth Conference on Tuesday, August 10, 2021, at 1:30 p.m. EDT. A recording will be available on the Investors section of the Company’s website at https://ir.thecronosgroup.com/events-presentations. About Cronos Group Inc.Cronos Group is an innovative global cannabinoid company with international production and distribution across five continents. Cronos Group is committed to building disruptive intellectual property by advancing cannabis research, technology and product development. With a passion to responsibly elevate the consumer experience, Cronos Group is...

NEW YORK, Aug. 09, 2021 (GLOBE NEWSWIRE) — Xcel Brands, Inc. (NASDAQ: XELB) (“Xcel” or the “Company”), a media and consumer products company, today announced that it will report its second quarter 2021 financial results after the market closes on August 12, 2021. The Company will hold a conference call with the investment community at 5:00 p.m. Eastern Time that day. A webcast of the conference call will be available live on the Investor Relations section of Xcel’s website at https://www.xcelbrands.com/. Interested parties unable to access the conference call via the webcast may dial 855-327-6838. A replay of the conference call will be available on the Company website for approximately two weeks following the event and can be accessed at 844-512-2921 using replay pin number 10016081. About Xcel BrandsXcel Brands, Inc. (NASDAQ:XELB)...

Central Nervous System Pipeline Progressing with Two Phase 2 Studies (TNX-1300 and TNX-1900) and One Phase 3 Study (TNX-102 SL) Expected to Start This Year COVID-19 Pipeline Progressing with First-in-Human Trial of TNX-2100, a Novel in vivo Skin Test for COVID-19 T cell Immunity, Expected to Start This Year New Advanced Development Center, Currently Under Construction, and Planned Acquisition of Infectious Disease R&D Facility Will Expand Internal R&D and Manufacturing Capabilities for Vaccines and Antiviral Therapeutics, With Initial Focus on COVID-19 At June 30, 2021, Cash and Cash Equivalents Totaled Approximately $166 Million CHATHAM, N.J., Aug. 09, 2021 (GLOBE NEWSWIRE) — Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced financial...

-Q2 2021 Total Net Revenues of $36.4 Million Reflect Strong Quarter over Quarter Growth -Q2 2021 GAAP Net Income of $12.2 Million; Non-GAAP Net Income of $17.4 Million -$155.3 Million in Cash and Investments and no Funded Debt at End of Q2-2021 -Catalyst to Host Quarterly Conference Call at 8:30 AM ET Tomorrow CORAL GABLES, Fla., Aug. 09, 2021 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq:CPRX), a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing and commercializing novel high-quality medicines for patients living with rare diseases, today reported financial results for the second quarter ended June 30, 2021 and provided a corporate update. “I am very pleased that our operational plan for 2021 and year to date financial results continue to deliver as originally...

NEW YORK, Aug. 09, 2021 (GLOBE NEWSWIRE) — INDUS Realty Trust, Inc. (Nasdaq: INDT) (“INDUS” or the “Company”), a U.S. based industrial/logistics REIT, today reported financial results for the three months ended June 30, 2021 (the “2021 second quarter”). 2021 Second Quarter & Recent HighlightsNet loss of $1.2 million for the 2021 second quarter compared to a net loss of $0.7 million for the three months ended June 30, 2020 (the “2020 second quarter”) Net Operating Income (“NOI”)1 of $7.3 million for the 2021 second quarter as compared to $6.8 million for the 2020 second quarter Cash NOI2 for industrial/logistics properties of $6.1 million for the 2021 second quarter as compared to $5.4 million for the 2020 second quarter Industrial/logistics portfolio was 95.3% leased; stabilized3 industrial/logistics portfolio was 99.4%...